Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial von BRUNSVIG, Paal Fr, AMUND KYTE, Jon, KERSTEN, Christian, SUNDSTRUM, Stein, MULLER, Mona, NYAKAS, Marta, HANSEN, Gaute L, GAUDERNACK, Gustav, AAMDAL, Steinar

Volltext

Correction: Jin et al. Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers. Int. J. Mol. Sci. 2024, 25 , 586 von Jin, Yixin, Dunn, Claire, Persiconi, Irene, Sike, Adam, Skorstad, Gjertrud, Beck, Carole, Kyte, Jon Amund

Volltext

Immune escape of cancer cells with beta2‐microglobulin loss over the course of metastatic melanoma von del Campo, Ana B., Kyte, Jon Amund, Carretero, Javier, Zinchencko, Svitlana, Méndez, Rosa, González‐Aseguinolaza, Gloria, Ruiz‐Cabello, Francisco, Aamdal, Steinar, Gaudernack, Gustav, Garrido, Federico, Aptsiauri, Natalia

Volltext

Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers von Jin, Yixin, Dunn, Claire, Persiconi, Irene, Sike, Adam, Skorstad, Gjertrud, Beck, Carole, Kyte, Jon Amund

Volltext

Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer von Brunsvig, Paal F., Guren, Tormod Kyrre, Nyakas, Marta, Steinfeldt-Reisse, Claudius H., Rasch, Wenche, Kyte, Jon Amund, Juul, Hedvig Vidarsdotter, Aamdal, Steinar, Gaudernack, Gustav, Inderberg, Else Marit

Volltext

Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors von Oei, Vincent Yi Sheng, Siernicka, Marta, Graczyk-Jarzynka, Agnieszka, Hoel, Hanna Julie, Yang, Weiwen, Palacios, Daniel, Almåsbak, Hilde, Bajor, Malgorzata, Clement, Dennis, Brandt, Ludwig, Önfelt, Björn, Goodridge, Jodie, Winiarska, Magdalena, Zagozdzon, Radoslaw, Olweus, Johanna, Kyte, Jon-Amund, Malmberg, Karl-Johan

Volltext

Transient redirection of T cells for adoptive cell therapy with telomerase-specific T helper cell receptors isolated from long term survivors after cancer vaccination von Kyte, Jon Amund, Fåne, Anne, Pule, Martin, Gaudernack, Gustav

Volltext

Serum cytokine profiles and metabolic tumor burden in patients with non-small cell lung cancer undergoing palliative thoracic radiation therapy von Eide, Hanne A., MD, Knudtsen, Ingerid Skjei, MSc, Sandhu, Vandana, PhD, Løndalen, Ayca M., MD, Halvorsen, Ann Rita, MSc, Abravan, Azadeh, MSc, Kure, Elin H., PhD, Bogsrud, Trond V., MD, PhD, Brustugun, Odd Terje, MD, PhD, Kyte, Jon Amund, MD, PhD, Malinen, Eirik, PhD, Helland, Åslaug, MD, PhD

Volltext

Development of a TGFβ-IL-2/15 Switch Receptor for Use in Adoptive Cell Therapy von Beck, Carole, Casey, Nicholas Paul, Persiconi, Irene, Moharrami, Neda Nejati, Sike, Adam, Jin, Yixin, Kyte, Jon Amund

Volltext

Noninvasive profiling of serum cytokines in breast cancer patients and clinicopathological characteristics von Jabeen, Shakila, Espinoza, Jaime A., Torland, Lilly Anne, Zucknick, Manuela, Kumar, Surendra, Haakensen, Vilde D., Lüders, Torben, Engebraaten, Olav, Børresen-Dale, Anne-Lise, Kyte, Jon Amund, Gromov, Pavel, Naume, Bjørn, Kristensen, Vessela, Gromova, Irina, Tekpli, Xavier

Volltext

Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer von Jin, Yixin, Lorvik, Kristina Berg, Jin, Yang, Beck, Carole, Sike, Adam, Persiconi, Irene, Kvaløy, Emilie, Saatcioglu, Fahri, Dunn, Claire, Kyte, Jon Amund

Volltext

Peripheral immune cells in metastatic breast cancer patients display a systemic immunosuppressed signature consistent with chronic inflammation von Chauhan, Sudhir Kumar, Dunn, Claire, Andresen, Nikolai Kragøe, Røssevold, Andreas Hagen, Skorstad, Gjertrud, Sike, Adam, Gilje, Bjørnar, Raj, Sunil Xavier, Huse, Kanutte, Naume, Bjørn, Kyte, Jon Amund

Volltext

Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial von Andresen, Nikolai Kragøe, Røssevold, Andreas Hagen, Quaghebeur, Claire, Gilje, Bjørnar, Boge, Beate, Gombos, Andrea, Falk, Ragnhild Sørum, Mathiesen, Randi R., Julsrud, Lars, Garred, Øystein, Russnes, Hege G., Lereim, Ragnhild Reehorst, Chauhan, Sudhir Kumar, Lingjærde, Ole Christian, Dunn, Claire, Naume, Bjørn, Kyte, Jon Amund

Volltext

Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab von Jabeen, Shakila, Zucknick, Manuela, Nome, Marianne, Dannenfelser, Ruth, Fleischer, Thomas, Kumar, Surendra, Lüders, Torben, von der Lippe Gythfeldt, Hedda, Troyanskaya, Olga, Kyte, Jon Amund, Børresen-Dale, Anne-Lise, Naume, Bjørn, Tekpli, Xavier, Engebraaten, Olav, Kristensen, Vessela

Volltext

Strategies for Improving the Efficacy of CAR T Cells in Solid Cancers von Kyte, Jon Amund

Volltext

Cancer vaccination with telomerase peptide GV1001 von Kyte, Jon Amund

Volltext

Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial von Røssevold, Andreas Hagen, Andresen, Nikolai Kragøe, Bjerre, Christina Annette, Gilje, Bjørnar, Jakobsen, Erik Hugger, Raj, Sunil Xavier, Falk, Ragnhild Sørum, Russnes, Hege Giercksky, Jahr, Thea, Mathiesen, Randi Ruud, Lømo, Jon, Garred, Øystein, Chauhan, Sudhir Kumar, Lereim, Ragnhild Reehorst, Dunn, Claire, Naume, Bjørn, Kyte, Jon Amund

Volltext

An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment von Tekpli, Xavier, Lien, Tonje, Røssevold, Andreas Hagen, Nebdal, Daniel, Borgen, Elin, Ohnstad, Hege Oma, Kyte, Jon Amund, Vallon-Christersson, Johan, Fongaard, Marie, Due, Eldri Undlien, Svartdal, Lisa Gregusson, Sveli, My Anh Tu, Garred, Øystein, Frigessi, Arnoldo, Sahlberg, Kristine Kleivi, Sørlie, Therese, Russnes, Hege G., Naume, Bjørn, Kristensen, Vessela N.

Volltext

Use of RNA Interference with TCR Transfer to Enhance Safety and Efficiency von Casey, Nicholas Paul, Kyte, Jon Amund, Fujiwara, Hiroshi

Volltext

Telomerase Peptide Vaccination Combined with Temozolomide: A Clinical Trial in Stage IV Melanoma Patients von KYTE, Jon Amund, GAUDERNACK, Gustav, DUELAND, Svein, TRACHSEL, Sissel, JULSRUD, Lars, AAMDAL, Steinar

Volltext